These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Repeated hepatic ischemia in combination with chemotherapy for liver carcinoid metastases. Van Cutsem E; Penninckx F; Filez L; Kerremans R; Vantrappen G Acta Gastroenterol Belg; 1993; 56(3-4):292-5. PubMed ID: 8266772 [TBL] [Abstract][Full Text] [Related]
43. Malignant insulinoma presenting as metastatic liver tumor. Case report and review of the literature. Baldelli R; Ettorre G; Vennarecci G; Pasimeni G; Carboni F; Lorusso R; Barnabei A; Appetecchia M J Exp Clin Cancer Res; 2007 Dec; 26(4):603-7. PubMed ID: 18365560 [TBL] [Abstract][Full Text] [Related]
44. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160 [TBL] [Abstract][Full Text] [Related]
45. [Chemo-embolization therapy of unresectable liver metastases using implantable infusion port]. Minami T; Awane Y Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2875-9. PubMed ID: 2551230 [TBL] [Abstract][Full Text] [Related]
46. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization. Nesović M; Cirić J; Radojković S; Zarković M; Durović M J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492 [TBL] [Abstract][Full Text] [Related]
47. Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma. Karatas F; Sahin S; Aytekin A; Hacioglu MB; Imamoglu GI; Altinbas M J Cancer Res Ther; 2018; 14(5):1149-1151. PubMed ID: 30197367 [TBL] [Abstract][Full Text] [Related]
48. Effectiveness of Liver-Directed Therapy for the Management of Intractable Hypoglycemia in Metastatic Insulinoma. Habibollahi P; Bai HX; Sanampudi S; Soulen MC; Dagli M Pancreas; 2020 Jul; 49(6):763-767. PubMed ID: 32541627 [TBL] [Abstract][Full Text] [Related]
55. The surgical and systemic management of neuroendocrine tumors of the pancreas. Abood GJ; Go A; Malhotra D; Shoup M Surg Clin North Am; 2009 Feb; 89(1):249-66, x. PubMed ID: 19186239 [TBL] [Abstract][Full Text] [Related]
56. Liver metastases 9 years after removal of a malignant insulinoma which was initially considered benign. Gonzalez-Gonzalez A; Recio-Cordova JM JOP; 2006 Mar; 7(2):226-9. PubMed ID: 16525209 [TBL] [Abstract][Full Text] [Related]
57. Multidisciplinary management of refractory insulinomas. Brown E; Watkin D; Evans J; Yip V; Cuthbertson DJ Clin Endocrinol (Oxf); 2018 May; 88(5):615-624. PubMed ID: 29205458 [TBL] [Abstract][Full Text] [Related]
58. Hepatic artery embolization for metastatic endocrine-secreting tumors of the pancreas. Report of two cases. Clouse ME; Lee RG; Duszlak EJ; Lokich JJ; Alday MT Gastroenterology; 1983 Nov; 85(5):1183-6. PubMed ID: 6194040 [TBL] [Abstract][Full Text] [Related]
59. Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy. Pommier R; Ronot M; Cauchy F; Gaujoux S; Fuks D; Faivre S; Belghiti J; Vilgrain V Ann Surg Oncol; 2014 Sep; 21(9):3077-83. PubMed ID: 24743912 [TBL] [Abstract][Full Text] [Related]
60. Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases. Naganuma A; Mayahara H; Morizane C; Ito Y; Hagihara A; Kondo S; Ueno H; Itami J; Okusaka T Jpn J Clin Oncol; 2012 Jul; 42(7):640-5. PubMed ID: 22525212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]